ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0318

The Association of CT-Detected Intra-Articular Mineralization with MRI-Detected Effusion-Synovitis and Hoffa’s Synovitis in Knee OA: The Multicenter Osteoarthritis Study

Jean Liew1, Gabriela Rabasa1, Mohamed Jarraya2, Ali Guermazi1, David Felson1, Beth Lewis3, John Lynch4, Michael Nevitt4, James Torner5 and Tuhina Neogi6, 1Boston University, Boston, MA, 2Massachusetts General Hospital, Boston, MA, 3University of Alabama at Birimingham, Birmingham, AL, 4University of California San Francisco, San Francisco, CA, 5University of Iowa, Iowa City, IA, 6Boston University School of Medicine, Boston, MA

Meeting: ACR Convergence 2023

Keywords: Computed tomography (CT), CPPD, Imaging, Magnetic resonance imaging (MRI), Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0308–0324) Osteoarthritis – Clinical Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Intra-articular (IA) deposition of calcium crystals (chondrocalcinosis), is common in knee OA. While calcium crystals can cause inflammatory arthritis, their contribution to joint inflammation in OA, as manifested by effusion-synovitis and Hoffa’s synovitis on MRI, is unclear. Clarifying the role of calcium crystal deposition in joint-level inflammation would provide improved understanding for the role of targeted cytokine therapy in those with IA mineralization. Prior studies have been limited by use of radiographs to detect chondrocalcinosis. In contrast, CT provides higher sensitivity for detecting IA mineralization as well as identifying potential tissue-specific effects of IA mineralization in OA. We aimed to evaluate the cross-sectional and longitudinal relation of CT-detected IA mineralization to effusion-synovitis and/or Hoffa’s synovitis on MRI with the hypothesis that IA mineralization contributes to the worsening of synovitis in OA.

Methods: We included participants from the Multicenter Osteoarthritis (MOST) Study who had knee radiographs, CTs, and MRIs. IA mineralization was assessed on CT at baseline using the Boston University Calcium Knee Score (BUCKS), a semi-quantitative 0-3 scoring of the extent of mineralization in Whole Organ MRI Score (WORMS) subregions. We categorized presence of mineralization as a BUCKS score >0 as follows: 1) anywhere in the knee (including cartilage, meniscus, joint capsule, ligaments); 2) cartilage; 3) meniscus. Effusion-synovitis and Hoffa’s synovitis were scored on MRI in one knee using MOAKS at baseline and two years later. For cross-sectional analyses, either effusion-synovitis and/or Hoffa’s synovitis were considered present with MOAKS ≥1 in either score. For longitudinal analyses, worsening was defined as an increase of ≥1 in MOAKS, for either effusion-synovitis and/or Hoffa’s synovitis scores. We evaluated the relation of IA mineralization to the presence of effusion-synovitis and/or Hoffa’s synovitis cross-sectionally and their worsening longitudinally, using binomial regression with generalized estimating equations. Analyses were adjusted for age, sex, and body mass index.

Results: We included 1668 participants (mean age 60±9, 56% female, mean BMI 28.5±5 kg/m2; 21% knees with radiographic OA) (Table). Any IA mineralization was present in 9.2%, effusion-synovitis in 49.1%, Hoffa’s synovitis in 29.3%. Overall, 16.7% had worsening of either effusion-synovitis and/or Hoffa’s synovitis on MRI at 2 years. The presence of any IA mineralization was associated with 30% higher prevalence of effusion-synovitis and/or Hoffa’s synovitis cross-sectionally (PR 1.3, 95% CI 1.1-1.5), and 20% higher risk of worsening longitudinally (RR 1.2, 95% CI 0.8-1.6) (Figure).

Conclusion: CT-detected IA mineralization in various tissues was modestly associated with effusion-synovitis and Hoffa’s synovitis at baseline and with worsening over 2 years. These findings are limited by the sample size.

Supporting image 1

FIGURE: Longitudinal relation of CT-detected intra-articular mineralization, by site, to MRI-detected effusion-synovitis and Hoffa’s synovitis worsening over 2 years

Supporting image 2

TABLE: Baseline characteristics of participants included in this analysis, n = 1668 individuals (1809 knees)


Disclosures: J. Liew: None; G. Rabasa: None; M. Jarraya: None; A. Guermazi: BICL, LLC, 11, ICM, Coval, TrialSpark, TissueGene, Medipost, 2, Novartis, 2, Pfizer, 2; D. Felson: None; B. Lewis: None; J. Lynch: None; M. Nevitt: None; J. Torner: None; T. Neogi: None.

To cite this abstract in AMA style:

Liew J, Rabasa G, Jarraya M, Guermazi A, Felson D, Lewis B, Lynch J, Nevitt M, Torner J, Neogi T. The Association of CT-Detected Intra-Articular Mineralization with MRI-Detected Effusion-Synovitis and Hoffa’s Synovitis in Knee OA: The Multicenter Osteoarthritis Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/the-association-of-ct-detected-intra-articular-mineralization-with-mri-detected-effusion-synovitis-and-hoffas-synovitis-in-knee-oa-the-multicenter-osteoarthritis-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-association-of-ct-detected-intra-articular-mineralization-with-mri-detected-effusion-synovitis-and-hoffas-synovitis-in-knee-oa-the-multicenter-osteoarthritis-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology